JAC Advance Access published online on March 23, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl098
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul, Korea
* To whom correspondence should be addressed. Objectives: To investigate appropriate antimicrobial agents, the optimal concentration and treatment duration for the antibiotic lock technique (ALT) to treat catheter-related infections caused by Staphylococcus epidermidis and Staphylococcus aureus. Methods: We evaluated the bacterial killing activity of vancomycin, teicoplanin, ciprofloxacin, rifampicin, cefazolin, gentamicin, nafcillin and erythromycin against biofilms formed by two strains of S. aureus and two strains of S. epidermidis. The effectiveness of the antibiotic lock was assayed after exposure to antibiotics (1, 5 and 10 mg/mL) for 1, 3, 5, 7, 10 or 14 days using an in vitro model of biofilms on polyurethane film. Results: The biofilms were completely sterile after exposure to vancomycin (5 mg/mL) for 5 days and teicoplanin (5 and 10 mg/mL) for 7 days. Ciprofloxacin and rifampicin (both 5 mg/mL) achieved eradication of the biofilms of both staphylococcal species more rapidly than vancomycin or teicoplanin. Significant biofilm eradication was not achieved with cefazolin, nafcillin, gentamicin and erythromycin at any of the time exposures examined. Conclusions: The data suggest that 5 mg/mL vancomycin, ciprofloxacin or rifampicin can eradicate S. epidermidis and S. aureus biofilms within 5 days. These findings warrant prospective clinical trials for the evaluation of the clinical efficacy of ALT for less than 10 days.
Received January 8, 2006
Revised March 2, 2006
Accepted March 2, 2006
Original article
In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci
Ji-Young Lee 1
,
Kwan Soo Ko 1
,
Kyong Ran Peck 2 *,
Won Sup Oh 2,
and
Jae-Hoon Song 3
2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Il-won dong, Kangnam-ku, Seoul 135-710, Korea
3 Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul, Korea; Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Il-won dong, Kangnam-ku, Seoul 135-710, Korea
Kyong Ran Peck, E-mail: krpeck{at}smc.samsung.co.kr
![]()
Abstract
These authors contributed equally to this work.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Qu, T. S. Istivan, A. J. Daley, D. A. Rouch, and M. A. Deighton Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms J. Med. Microbiol., April 1, 2009; 58(4): 442 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Rose and P. T. Poppens Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus J. Antimicrob. Chemother., March 1, 2009; 63(3): 485 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Lee, K. S. Ko, J.-H. Song, and K. R. Peck In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae J. Antimicrob. Chemother., October 1, 2007; 60(4): 782 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. LaPlante and L. A. Mermel In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2239 - 2246. [Abstract] [Full Text] [PDF] |
||||


